AIMOS aims to make the research process more trustworthy and efficient, and to promote the study of how research is done and how it can be improved. AIMOS 2025 will bring together researchers from multiple disciplines to talk about how research is done and how we can do it better.
AIMOS 2025 will be held from 19 to 21 November at The University of Sydney, in Camperdown, on the lands of Gadigal people of the Eora Nation. The ARDC is proud to be a sponsor of AIMOS 2025.
Preceding the AIMOS conference is the International Research Integrity Conference, which will be held in Randwick, Sydney from 17 to 18 November, and the Australasian Ethics Network Conference, held in Newcastle from 6 to 7 November.
Plenary speakers for AIMOS 2025 include:
The ARDC is running the following session at AIMOS 2025:
Sharing clinical data for secondary research offers significant potential for accelerated discovery, quality of research, and promotes interdisciplinary collaboration. However, health data is inherently sensitive and therefore subject to rigorous controls for privacy, ethics, security, and location. Further, methodologies and skills to conduct secondary health research are not widespread, which limits the potential impact of such work.
To address these barriers, the ARDC is building national research infrastructure to enhance the discoverability, access, and reuse of health data through the Health Studies Australian National Data Asset program (HeSANDA).
The aims for this workshop are to showcase harmonised standards, and to demonstrate the processes, technology, and resources developed to mobilise health data for secondary use. We also invite multi-disciplinary input on how these approaches can be utilised, enhanced, and reused across diverse research domains.
We will also host a discussion with participants about the establishment of a community of practice for secondary use of highly protected data, focused on health data and enriched through inter-disciplinary collaborations.
Throughout this workshop participants will gain practical knowledge, resources, and a call to action to advance the safe and effective secondary use of health data.
This year, AIMOS is partnering with the Evidence, Policy, and Influence Collaborative (EPIC) at the University of Sydney to spotlight commercial determinants of health at AIMOS 2025.
Commercial determinants of health refer to private sector activities that influence public health, and the political and economic systems and norms that enable them. Corporate or industry sponsorship of health and other research can bias how studies are designed, conducted, analysed and reported, and systematically over- or underestimate true research findings to present conclusions that favour the sponsor’s product. Examples of corporate influence on research are known in big food, tobacco, pharmaceuticals, gambling, alcohol, and the environment on health. Minimising bias in research due to corporate influence, as well as methodological limitations are essential to research integrity and public policy.
At AIMOS 2025, speakers and sessions will explore both the metaresearch issues we are known for, as well as the influences of commercial determinants of health, policy responses, and solutions to address these biases.
For more information, visit the AIMOS 2025 website.
Do you have questions about this event? Email Joanna Diong at [email protected].
